Glenmark Pharmaceuticals Limited
$12.97
24H
Market Cap
Volume
Supply
Price Chart
About Glenmark Pharmaceuticals Limited - GLENMARK.BO
Glenmark Pharmaceuticals Limited is a global pharmaceutical company headquartered in Mumbai, India, focused on the discovery, development, and marketing of generic drugs and active pharmaceutical ingredients across various therapeutic areas. It operates in regions including North America, Europe, Latin America, Africa, the Middle East, Russia, and the Asia-Pacific, aiming to improve patient quality of life worldwide.
What are Glenmark Pharmaceuticals Limited's core values and mission statement?
Glenmark Pharmaceuticals Limited's mission is to enrich lives across the world by discovering, developing, and providing innovative pharmaceutical products that help improve the quality of life. Their core values center around driving growth through innovation, placing patients first, emphasizing world-class quality, fostering individual ability and accountability, and ensuring integrity in all their actions.
Who founded Glenmark Pharmaceuticals Limited and when?
Glenmark Pharmaceuticals Limited was founded by Gracias Saldanha in 1977.
Who leads Glenmark Pharmaceuticals Limited?
As of my last update, Glenmark Pharmaceuticals Limited was led by Glenn Saldanha, who holds the positions of Chairman and Managing Director.
Where is Glenmark Pharmaceuticals Limited located, and what is its base country?
Glenmark Pharmaceuticals Limited is headquartered in Mumbai, Maharashtra, India, which is also its base country.
On which exchanges is Glenmark Pharmaceuticals Limited traded?
Glenmark Pharmaceuticals Limited is traded on the Bombay Stock Exchange (BSE) and the National Stock Exchange of India (NSE).
Historical data
Glenmark Pharmaceuticals Limited (GLENMARK) Price Live Data
The live price of Glenmark Pharmaceuticals Limited (GLENMARK) is $12.97, with a trading volume of 12,780 in the last 24 hours. Wrapstocks updates the GLENMARK price in real-time. Glenmark Pharmaceuticals Limited is down -0.06% in the last 24 hours. The company has a live market cap of $3,659,520,643.56 and a supply of 282,187,999 GLENMARK stocks.
Glenmark Pharmaceuticals Limited (GLENMARK) is traded on Bombay Stock Exchange, and currently, the market is closed; trading will be resumed in 9 hours and 52 minutes.